Storage of Enbrel® is convenient1
TNFi therapies approved for RA1-5
Adapted from Enbrel® LPD. Version LPDENB062021; Humira SmPC; Remicade SmPC; Simponi SmPC; Simponi PI; Cimzia SmPC.
*2 °C to 8 °C.
LPD, local product document; PI, prescribing information; RA, rheumatoid arthritis; SmPC, summary of product characteristics; TNFi, tumour necrosis factor inhibitor.
Please click the Prescribing Information link to view the safety and adverse events information of Enbrel®.
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory.
PP-ENB-IND-0814 August 2022
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered medical practitioner*, please visit "https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf", Page No. 39, Rule 2 part (ee), last accessed on 26th April 2021.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.